name: Hemochromatosis
category: Mendelian
disease_term:
  preferred_term: hereditary hemochromatosis
  term:
    id: MONDO:0006507
    label: hereditary hemochromatosis
parents:
  - Iron Metabolism Disorders
  - Hereditary Metabolic Diseases
pathophysiology:
  - name: HFE Loss Lowers Hepcidin
    description: >
      Pathogenic HFE variants (most commonly C282Y homozygosity) blunt hepcidin induction,
      leaving circulating hepcidin inappropriately low relative to body iron stores.
    evidence:
      - reference: PMID:23985001
        supports: SUPPORT
        snippet: "Hereditary hemochromatosis is an inherited iron overload disorder caused by inappropriately low hepcidin secretion leading to increased duodenal absorption of dietary iron, most commonly in C282Y homozygous individuals."
        explanation: Impaired HFE signaling results in low hepcidin in C282Y homozygotes.
    biological_processes:
      - preferred_term: iron ion homeostasis
        term:
          id: GO:0055072
          label: iron ion homeostasis

  - name: Low Hepcidin Leads to Ferroportin Hyperabsorption
    description: >
      Suppressed hepcidin fails to internalize and degrade ferroportin on enterocytes, so
      dietary iron efflux into plasma is unchecked, driving systemic iron overload.
    evidence:
      - reference: PMID:23985001
        supports: SUPPORT
        snippet: "Hereditary hemochromatosis is an inherited iron overload disorder caused by inappropriately low hepcidin secretion leading to increased duodenal absorption of dietary iron"
        explanation: Low hepcidin permits unregulated ferroportin-mediated iron export from the gut.
    biological_processes:
      - preferred_term: iron ion transport
        term:
          id: GO:0006826
          label: iron ion transport
  - name: Hepatic Iron Toxicity
    description: >
      Excess iron deposits in hepatocytes leading to oxidative stress, lipid peroxidation,
      and hepatocellular damage. Progressive iron accumulation causes fibrosis and can
      lead to cirrhosis and hepatocellular carcinoma.
    evidence:
      - reference: PMID:37763705
        supports: SUPPORT
        snippet: "The key organ that is affected by iron overload is the liver, suffering from fibrosis, cirrhosis or hepatocellular carcinoma"
        explanation: Liver iron overload drives fibrotic injury and malignant risk.
    cell_types:
      - preferred_term: hepatocyte
        term:
          id: CL:0000182
          label: hepatocyte
    biological_processes:
      - preferred_term: cellular response to oxidative stress
        term:
          id: GO:0034599
          label: cellular response to oxidative stress
  - name: Cardiac Iron Deposition
    description: >
      Iron accumulation in cardiomyocytes causes oxidative damage and impaired contractility,
      leading to cardiomyopathy and cardiac failure, particularly dilated cardiomyopathy.
    evidence:
      - reference: PMID:35449524
        supports: SUPPORT
        snippet: "Hemochromatosis type 2 or juvenile hemochromatosis has an early onset of severe iron overload resulting in organ manifestation such as liver fibrosis, cirrhosis, cardiomyopathy, arthropathy, hypogonadism, diabetes"
        explanation: Early severe iron overload includes cardiomyopathy, consistent with cardiac iron toxicity.
    cell_types:
      - preferred_term: cardiac muscle cell
        term:
          id: CL:0000746
          label: cardiac muscle cell
    biological_processes:
      - preferred_term: cellular response to oxidative stress
        term:
          id: GO:0034599
          label: cellular response to oxidative stress
  - name: Pancreatic Iron Toxicity
    description: >
      Iron deposition in pancreatic beta cells causes oxidative damage and impaired insulin
      secretion, leading to diabetes mellitus ("bronze diabetes").
    evidence:
      - reference: PMID:38886778
        supports: SUPPORT
        snippet: "Magnetic resonance imaging showed iron deposition in the liver, spleen, and pancreas, along with cirrhosis and splenomegaly."
        explanation: Imaging confirms pancreatic iron deposition contributing to endocrine dysfunction.
    cell_types:
      - preferred_term: type B pancreatic cell
        term:
          id: CL:0000169
          label: type B pancreatic cell
    biological_processes:
      - preferred_term: cellular response to oxidative stress
        term:
          id: GO:0034599
          label: cellular response to oxidative stress
phenotypes:
  - name: Hepatomegaly
    description: >
      Enlarged liver due to iron accumulation in hepatocytes, often the earliest
      detectable physical finding.
    phenotype_term:
      preferred_term: hepatomegaly
      term:
        id: HP:0002240
        label: Hepatomegaly
    evidence:
      - reference: PMID:37168645
        supports: SUPPORT
        snippet: "One of the most serious clinical characteristics associated with early-onset iron overload is liver disease with eventual cirrhosis"
        explanation: Liver involvement early in disease course leads to enlargement and progression to cirrhosis.
  - name: Skin Hyperpigmentation
    description: >
      Bronze or grayish skin discoloration due to increased melanin and iron deposition
      in the dermis, a classic feature of hemochromatosis.
    phenotype_term:
      preferred_term: generalized bronze hyperpigmentation
      term:
        id: HP:0007574
        label: Generalized bronze hyperpigmentation
    evidence:
      - reference: PMID:38886778
        supports: SUPPORT
        snippet: "The proband is a 64-year-old man complaining of persistent abnormality of liver enzyme levels for 1 year, with a history of knee joint pain, diabetes and skin pigmentation."
        explanation: Case report documents skin pigmentation in ferroportin-related hemochromatosis.
  - name: Diabetes Mellitus
    description: >
      Development of diabetes due to pancreatic beta cell destruction from iron toxicity,
      historically called "bronze diabetes."
    phenotype_term:
      preferred_term: diabetes mellitus
      term:
        id: HP:0000819
        label: Diabetes mellitus
    evidence:
      - reference: PMID:38886778
        supports: SUPPORT
        snippet: "The proband is a 64-year-old man complaining of persistent abnormality of liver enzyme levels for 1 year, with a history of knee joint pain, diabetes and skin pigmentation."
        explanation: Diabetes reported as part of the hemochromatosis presentation.
  - name: Arthropathy
    description: >
      Joint pain and swelling, particularly affecting the second and third
      metacarpophalangeal joints, due to iron and calcium pyrophosphate deposition.
    phenotype_term:
      preferred_term: arthropathy
      term:
        id: HP:0003040
        label: Arthropathy
    evidence:
      - reference: PMID:38886778
        supports: SUPPORT
        snippet: "The proband is a 64-year-old man complaining of persistent abnormality of liver enzyme levels for 1 year, with a history of knee joint pain, diabetes and skin pigmentation."
        explanation: Knee joint pain in hemochromatosis supports arthropathy association.
  - name: Cardiomyopathy
    description: >
      Heart muscle disease due to iron deposition in cardiomyocytes, which can lead
      to heart failure and arrhythmias.
    phenotype_term:
      preferred_term: cardiomyopathy
      term:
        id: HP:0001638
        label: Cardiomyopathy
    evidence:
      - reference: PMID:35449524
        supports: SUPPORT
        snippet: "Hemochromatosis type 2 or juvenile hemochromatosis has an early onset of severe iron overload resulting in organ manifestation such as liver fibrosis, cirrhosis, cardiomyopathy, arthropathy, hypogonadism, diabetes"
        explanation: Juvenile hemochromatosis case describes cardiomyopathy among manifestations.
  - name: Hypogonadism
    description: >
      Decreased gonadal function due to iron deposition in the pituitary gland,
      leading to reduced libido, erectile dysfunction, and testicular atrophy.
    phenotype_term:
      preferred_term: hypogonadotropic hypogonadism
      term:
        id: HP:0000044
        label: Hypogonadotropic hypogonadism
    evidence:
      - reference: PMID:36644615
        supports: SUPPORT
        snippet: "Pituitary haemochromatosis is an endocrine disorder caused by the accumulation of iron due to a lack of absorption during haemochromatosis."
        explanation: Pituitary iron deposition disrupts gonadotropin signaling leading to hypogonadism.
  - name: Fatigue
    description: >
      Chronic tiredness and weakness, one of the most common and earliest symptoms
      of hemochromatosis.
    phenotype_term:
      preferred_term: fatigue
      term:
        id: HP:0012378
        label: Fatigue
treatments:
  - name: Phlebotomy (Therapeutic Venesection)
    description: >
      Regular blood removal is the primary treatment, which reduces iron stores by
      requiring the body to use iron for new red blood cell production. Initially
      weekly until iron stores normalize, then maintenance every 2-3 months.
    evidence:
      - reference: PMID:23985001
        supports: SUPPORT
        snippet: "Phlebotomy remains the mainstay of treatment and new treatments being studied include erythrocytapheresis and 'mini-hepcidins'."
        explanation: "This review confirms phlebotomy as the standard first-line treatment for hereditary hemochromatosis."
      - reference: PMID:38886778
        supports: SUPPORT
        snippet: "Four patients with organ damage in the present study received therapeutic phlebotomy, alleviating clinical symptoms and improving in transferrin saturation and serum ferritin."
        explanation: Phlebotomy improved iron indices and symptoms in a ferroportin hemochromatosis pedigree.
      - reference: PMID:37121243
        supports: SUPPORT
        snippet: "Early diagnosis by genetic testing and therapy by periodic phlebotomy can prevent the most serious complications, which include liver cirrhosis, liver cancer, and death."
        explanation: Seminar notes phlebotomy prevents cirrhosis and mortality when started early.
      - reference: PMID:35662478
        supports: SUPPORT
        snippet: "Early diagnosis and treatment by phlebotomy can prevent cirrhosis, hepatocellular carcinoma, diabetes, arthropathy and other complications."
        explanation: EASL guideline highlights phlebotomy as preventive for multi-organ complications.
      - reference: PMID:5339192
        supports: SUPPORT
        snippet: "The treatment of hemochromatosis by phlebotomy."
        explanation: Early clinical report established phlebotomy as definitive iron removal.
  - name: Iron Chelation Therapy
    description: >
      Deferoxamine or oral chelators (deferasirox, deferiprone) are used when
      phlebotomy is contraindicated or insufficient, such as in patients with anemia.
    evidence:
      - reference: PMID:19727383
        supports: SUPPORT
        snippet: "Because secondary hemochromatosis is due to hereditary or acquired anemia, phlebotomy is not a suitable means of removing excess iron in this situation. Rather, the treatment is based on the targeted elimination of iron by means of iron chelators."
        explanation: Secondary hemochromatosis requires chelation when phlebotomy is not feasible.
      - reference: PMID:29620054
        supports: SUPPORT
        snippet: "The mainstay therapy is phlebotomy, although iron chelation can be used in some patients."
        explanation: Primer notes chelation as an alternative for selected patients.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
  - name: Dietary Modification
    description: >
      Avoiding iron supplements, limiting vitamin C intake (which enhances iron
      absorption), and reducing alcohol consumption to protect the liver.
    treatment_term:
      preferred_term: dietary intervention
      term:
        id: MAXO:0000088
        label: dietary intervention
  - name: Screening of Family Members
    description: >
      Genetic testing of first-degree relatives is recommended given the autosomal
      recessive inheritance pattern and the benefits of early intervention.
    treatment_term:
      preferred_term: genetic counseling
      term:
        id: MAXO:0000079
        label: genetic counseling
differential_diagnoses:
  - name: Secondary/Transfusional Iron Overload
    description: >
      Iron accumulation from chronic transfusions or ineffective erythropoiesis can mimic hereditary hemochromatosis but occurs in anemic patients where phlebotomy is not feasible.
    distinguishing_features:
      - History of chronic transfusions or underlying anemia (e.g., thalassemia, MDS)
      - Phlebotomy contraindicated due to anemia; chelation preferred
      - Iron loading often involves reticuloendothelial system in addition to parenchyma
    evidence:
      - reference: PMID:19727383
        supports: SUPPORT
        snippet: "Because secondary hemochromatosis is due to hereditary or acquired anemia, phlebotomy is not a suitable means of removing excess iron in this situation. Rather, the treatment is based on the targeted elimination of iron by means of iron chelators."
        explanation: Highlights anemia/transfusion-related iron overload where chelation is required instead of phlebotomy.
  - name: Ferroportin Disease (SLC40A1-Related Hemochromatosis)
    description: >
      Autosomal dominant iron overload from gain-of-function SLC40A1 variants can present with high ferritin and iron deposition, necessitating distinction from HFE-hemochromatosis.
    distinguishing_features:
      - Often autosomal dominant inheritance pattern
      - Elevated ferritin with variable transferrin saturation; iron may accumulate in macrophages and liver
      - Genetic testing reveals SLC40A1 variants affecting ferroportin
    evidence:
      - reference: PMID:38886778
        supports: SUPPORT
        snippet: "SLC40A1-related haemochromatosis is associated with gain-of-function mutations in the SLC40A1 gene, which encodes ferroportin."
        explanation: Establishes ferroportin-associated iron overload as a distinct entity to differentiate.
genetic:
  - name: HFE Mutations
    association: Causative
    notes: Most common mutation is C282Y (p.Cys282Tyr) homozygosity, accounting for 80-90% of hereditary hemochromatosis cases. H63D (p.His63Asp) compound heterozygosity also contributes.
    inheritance:
      - name: Autosomal Recessive
    evidence:
      - reference: PMID:23985001
        supports: SUPPORT
        snippet: "most commonly in C282Y homozygous individuals"
        explanation: "Review confirms C282Y homozygosity as the most common cause of hereditary hemochromatosis."
datasets:
